| Title | Date | PubMed ID |
|---|
| Structure of sulfamidase provides insight into the molecular pathology of mucopolysaccharidosis IIIA. | 2014 May | 24816101 |
| Residual activity and proteasomal degradation of p.Ser298Pro sulfamidase identified in patients with a mild clinical phenotype of Sanfilippo A syndrome. | 2011 Jul | 21671382 |
| Gastrointestinal pathology in a mouse model of mucopolysaccharidosis type IIIA. | 2009 May | 19170061 |
| Primary culture of neural cells isolated from the cerebellum of newborn and adult mucopolysaccharidosis type IIIA mice. | 2008 Nov | 18297392 |
| Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice. | 2008 Oct | 18518922 |
| Mannose 6-phosphate receptor-mediated transport of sulfamidase across the blood-brain barrier in the newborn mouse. | 2008 Jul | 18443601 |
| The mutation p.Ser298Pro in the sulphamidase gene (SGSH) is associated with a slowly progressive clinical phenotype in mucopolysaccharidosis type IIIA (Sanfilippo A syndrome). | 2008 May | 18407553 |
| Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA. | 2008 Apr | 18248829 |
| Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes. | 2007 Nov 15 | 17725987 |
| Systemic inflammation and neurodegeneration in a mouse model of multiple sulfatase deficiency. | 2007 Mar 13 | 17360554 |